SOLICITATION NOTICE
A -- Highly Potent Cancer Therapeutics using Nanotechnology - S10-028 Highly Potent Cancer Therapeutics using Nanotechnology
- Notice Date
- 9/1/2009
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bldg 427, Room 12, Frederick, Maryland, 21702
- ZIP Code
- 21702
- Solicitation Number
- S10-028
- Archive Date
- 10/14/2009
- Point of Contact
- Lynne Darby, Phone: 301 228 4021
- E-Mail Address
-
darbyl@mail.nih.gov
(darbyl@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Highly Potent Cancer Therapeutics using Nanotechnology RFP RFP S10-028. PROPOSALS MUST BE RECEIVED BY 3:00 P.M., Eastern Daylight Time, September 29, 2009. It is the Offerors responsibility to ensure that proposals are delivered by the due date and time required. Late proposals will not be accepted. All questions or requests for clarifications must be e-mailed (No telephone calls accepted) to Lynne Darby at darbyl@mail.nih.gov, or by facsimile at 301-228-4037 by 3:00 P.M., Eastern Daylight Time, September 15, 2009. Questions or requests directed to any other individual or outside the directives of this Solicitation will not be considered valid, nor will there be a response provided. SAIC-Frederick, Inc., on behalf of the The National Cancer Institute, NCI, is seeking offerors to submit proposals for nanotherapeutics that are in the post-optimization phase of the development cycle, and require evaluation in appropriate preclinical animal models of the disease for determination of both efficacy and safety profiles of the nanodevice and the targeted chemotherapeutic payload. The purpose of this Request for Proposals (RFP) is to identify and evaluate the potential of candidate nanotechnologies to improve the bioavailability, solubility, pharmacokinetics, or therapeutic index of a range of drugs that would otherwise fail as anti-cancer agents. The NCI Alliance for Nanotechnology is interested in identifying these technologies at academic institutions, nanotechnology-focused pharmaceutical companies, and biotechnology companies.This acquisition shall be conducted in a two-Phase approach. Once received, all proposals will be evaluated on the basis of technical merit, and a decision will be made to select a minimum of one, and possibly multiple awards.Specifics are outlined in detail in the attached Request for Proposals, S10-028.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/FCRF/S10-028/listing.html)
- Place of Performance
- Address: Contractor's site., United States
- Record
- SN01935913-W 20090903/090902004654-f89c3c3c3c6e81585c9a748ba156f33c (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |